DLL3 and neoplasm: Daily oral administration of HOC in a nude mouse NEPC xenograft model markedly suppressed the tumor expression of EPHA3 and BRN2, along with their downstream effectors EZH2, ASCL1, and DLL3 and neuroendocrine markers SYP and CHGA.